Introducing:

InTandem™

A clinically-validated neurorehabiliation system intended to improve walking and ambulation in adults with chronic stroke.

Now listed with the United States Food and Drug Administration (FDA)! InTandem is the brand name for MR-001.

Read the press release for additional details

Introducing:

InTandem™

A clinically-validated neurorehabilitation system intended to improve walking and ambulation in adults with chronic stroke

Now listed by the United States Food and Drug Administration (FDA)! InTandem is the brand name for MR-001.
Read the press release for additional details

According to the CDC, stroke is a leading cause of long-term disability, and over half of people aged 65 or older who have had a stroke experience reduced mobility and gait deficits.

Learn more about including InTandem in your stroke rehabilitation toolkit! Healthcare providers, patients & caregivers, and health plans are encouraged to sign up to receive updates from MedRhythms regarding product information and availability.

Make your next step your best step.